Human data on SGLT2 inhibitors show remarkable impact on kidney failure, all-cause mortality, and heart failure.

“although the human data on the sglt2 Inhibitors is also remarkable and I think that's yeah you know that's the sort of that's the theme Here Right is you have a great ITP outcome and of course the human data are not for longevity but they're again they suffer the the limitations of all human studies namely that they're being used in a subset of the population that might not be the subset of interest but you know the impact on kidney failure all cause mortality heart failure uh is is pretty impressive”